Frequently Asked Questions & Answers

About PTLD

what are the risk factors for getting ptld?

The primary risk factor for developing EBV-related PTLD is immune suppression. Rates of PTLD cancer are higher for people who have types of bone marrow and organ transplants that require higher levels of immunosuppression. To learn more about other possible risk factors, please discuss this with your treating physician or an Atara representative.

are there different types of ptld?

There are different types of PTLD, with each type having its own unique characteristics. However, your treating physician or an Atara representative will be able to tell you more about the different types of PTLD.

ABOUT CLINICAL Studies

WHAT IS A Phase 3 CLINICAL STUDY?

A clinical study is designed to understand whether an investigational treatment is safe and effective for humans. There are usually several phases of studies, each designed to learn more about the investigational treatment’s effects. When a clinical study is in an early phase (Phase 1), the purpose is to gather information on the safety and dosage. As more is learned about an investigational treatment, a later phase (Phase 3) clinical study is designed to evaluate efficacy (effectiveness) and safety.

All clinical studies must follow a strict set of rules that are outlined in the study’s protocol. These rules set specific requirements on which types of patients can be included in the study, procedures that must be followed, and the number of required study visits for the participants.

Because of these rules, it is important that patients who participate carefully follow the visit schedule and instructions of the personnel conducting the studies. Clinical studies are required for all new treatments in order to show that the treatment is safe and effective before it can be made available to the general population.

WHY ARE CLINICAL STUDIES CONDUCTED?

Clinical studies are conducted to answer research questions and to learn if a certain investigational treatment is safe and effective. The main questions the researchers want to answer are:

  • Does this investigational treatment work?

  • What side effects does this investigational treatment cause?

  • Do the benefits of the investigational treatment outweigh the risks?

  • Which patients are most likely to find this investigational treatment helpful?

WHY SHOULD I PARTICIPATE IN A CLINICAL STUDY?

Participating in a clinical study is a voluntary opportunity. It is always up to you and your treating physician to determine if you should participate in a clinical study. Many people participate in clinical studies for these reasons, if applicable:

  • There is no current approved treatment for their disease

  • They have not experienced improvement of the condition after using the currently available treatments

  • They want access to a new type of treatment even if it is not guaranteed to be better or as good as already available treatments

  • They want to contribute to the development of a new treatment for others with a similar disease

ABOUT CLINICAL STUDies FOR PTLD CANCER

WHAT IS INVOLVED IN these CLINICAL STUDies FOR PTLD CANCER?

These clinical studies are enrolling patients who have been diagnosed with EBV-related PTLD cancer. If you or your loved one has been diagnosed with cancer after they received a bone marrow or organ transplant, please click here to learn more about PTLD cancer and an investigational treatment option. These are single arm, open-label studies, so every participant will receive the investigational treatment.

Prior to enrolling in a clinical study, you will need to understand what is involved by talking to the study staff and reading the Informed Consent Form. The Informed Consent Form outlines the known significant safety information for an investigational treatment and what is involved in the study.

Once the Informed Consent Form is signed, you will visit your study doctor for certain tests to make sure you are eligible to be included. Your study doctor and study team will be available to answer any questions that you might have as you go through the process.

It's also important to remember to always consult with your treating physician if you have questions about your disease and its treatment.

WHAT SIDE EFFECTS SHOULD I EXPECT?

The Informed Consent Form will review in detail the significant safety information known about the investigational treatment. After you read it, please direct any questions to your study doctor.

DOES THIS CLINICAL RESEARCH STUDY OFFER TRAVEL REIMBURSEMENT?

Participants in this clinical study may qualify for reimbursement related to travel to study visits as each situation is reviewed on a case-by-case scenario.

HOW DO I GET STARTED?

Please click here to provide your contact information and answer a few questions if you wish to learn more about PTLD cancer and an investigational treatment option. A representative will then contact you to give you more information.